EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

Epithelial–Mesenchymal Plasticity in Cancer: Transcriptional Regulation, Biomarker Challenges, and Emerging Therapeutic Opportunities

Dhrruv Shah iD, Rajasekhar Reddy Alavala iD

Cell Biochemistry and Function · 2026-07 · 44 (7)

DOI: 10.1002/cbf.70271 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cell Biochemistry and Function, online erschienen am 17.07.2026. Verfasst von Dhrruv Shah und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Quality Assurance, Shobhaben Pratapbhai Patel School of Pharmacy and Technology Management, SVKM's NMIMS University, Mumbai, Maharashtr…. Hauptthemen laut MEDLINE: Epithelial-Mesenchymal Transition, Neoplasms. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 119 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Epithelial–mesenchymal transition (EMT) is increasingly recognized as a dynamic process of epithelial–mesenchymal plasticity (EMP) rather than a binary switch between epithelial and mesenchymal phenotypes. This plasticity enables tumor cells to acquire invasive, metastatic, stem‐like, and therapy‐resistant characteristics that contribute to cancer progression and poor clinical outcomes. Despite extensive investigation, significant challenges remain in understanding the functional significance of partial EMT states, identifying robust biomarkers that capture EMT heterogeneity, and translating EMT‐targeted interventions into clinical practice. This review critically examines the molecular mechanisms governing EMT, including transcriptional regulators, signaling pathways, epigenetic modifications, and tumor microenvironmental influences. Particular emphasis is placed on hybrid epithelial/mesenchymal states, which have emerged as key drivers of metastatic fitness and therapeutic resistance. We further evaluate established and emerging EMT biomarkers, including E‐cadherin, N‐cadherin, vimentin, circulating tumor cells, and exosome‐derived signatures, highlighting their opportunities and limitations in clinical applications. Finally, we discuss current therapeutic strategies targeting EMT‐associated pathways and explain why many promising preclinical approaches have faced translational barriers. By integrating mechanistic, biomarker, and therapeutic perspectives, this review proposes that understanding and targeting epithelial–mesenchymal plasticity, rather than EMT alone, may provide a more effective framework for precision oncology and metastasis prevention.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Epithelial-Mesenchymal TransitionNeoplasmsHumansAnimalsBiomarkersMolecular Targeted TherapyDrug Resistance, NeoplasmGene Expression Regulation, Neoplastic

Stichwörter der Autor:innen

EMT biomarkerscancer progressionepithelial–mesenchymal transitionmetastasissignaling pathwaystranscription factorstumor microenvironment

Substanzen

Biomarkers

Autor:innen und Institutionen

  • Department of Quality Assurance, Shobhaben Pratapbhai Patel School of Pharmacy and Technology Management, SVKM's NMIMS University, Mumbai, Maharashtra, India.
  • Department of Pharmaceutical Chemistry, Shobhaben Pratapbhai Patel School of Pharmacy and Technology Management, SVKM's NMIMS University, Mumbai, Maharashtra, India.

ORCID-Profile: Dhrruv Shah, Rajasekhar Reddy Alavala

Zitieren

APA

Shah, D., & Alavala, R. R. (2026). Epithelial–Mesenchymal Plasticity in Cancer: Transcriptional Regulation, Biomarker Challenges, and Emerging Therapeutic Opportunities. Cell Biochemistry and Function, 44(7). https://doi.org/10.1002/cbf.70271

Vancouver

Shah D, Alavala RR. Epithelial–Mesenchymal Plasticity in Cancer: Transcriptional Regulation, Biomarker Challenges, and Emerging Therapeutic Opportunities. Cell Biochemistry and Function. 2026;44(7). doi:10.1002/cbf.70271

BibTeX
@article{Shah2026,
  author = {Shah, Dhrruv and Alavala, Rajasekhar Reddy},
  title = {Epithelial–Mesenchymal Plasticity in Cancer: Transcriptional Regulation, Biomarker Challenges, and Emerging Therapeutic Opportunities},
  journal = {Cell Biochemistry and Function},
  year = {2026},
  volume = {44},
  number = {7},
  doi = {10.1002/cbf.70271}
}
Kostenlos starten →